用于预测瓦尔酸诱导的血小板衰减的诺莫грам:一个嵌套的病例对照研究
Gang Cheng1, Xinfeng Cai2, Tianning Zhang3
1Department of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, People's Republic of China.
Scientific reports
|March 22, 2025
概括
瓦尔酸可以导致神经外科患者的血小板减少. 晚年和将酸与 levetiracetam 结合增加风险,而较低的酸水平可以防止这种副作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 瓦尔酸经常用于预防神经外科患者的发作.
- 血小板减少 (血小板缺血) 是一种已知的酸治疗并发症.
- 瓦尔酸诱导的血小板缩的危险因素以及 levetiracetam 等同时服用药物的影响尚不清楚.
研究的目的:
- 在神经外科患者中,鉴定瓦尔酸诱导的血小板衰减的危险因素.
- 开发和验证一个预测模型,用于瓦尔酸相关的血小板缺血.
- 评估 levetiracetam 在与酸联合治疗中对血小板计数的作用.
主要方法:
- 这是一项回顾性嵌套病例控制研究,涉及356名神经外科患者.
- 多变量物流回归分析以确定独立的风险和保护因素.
- 使用曲线下的面积 (AUC) 和校准图表开发和验证预测性名ogram.
主要成果:
- 晚年 (OR:1.05) 和与酸和 levetiracetam (OR:3.03) 的联合治疗被确定为血小板减少的独立风险因素.
- 最低酸度低于100微克/毫升 (OR:0.41) 是一个独立的保护因子.
- 预测模型表现出强大的性能,AUC值为0.85 (训练) 和0.81 (验证).
结论:
- 结合年龄,酸-莱维他组合和酸最低度的预测模型可以有效评估血小板减少的风险.
- 该模型有助于在神经外科患者中管理酸治疗.
- 识别患有高血小板缺血风险的患者可以进行主动监测和潜在干预.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
Dosage Regimen Designs: Nomograms and Tabulations
360
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
360
Drug Toxicity: Risk factors
248
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
248


